Eudaimonia Partners’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $223K | Hold |
14,763
| – | – | 0.05% | 236 |
|
|
2023
Q4 | $318K | Buy |
14,763
+2,247
| +18% | +$48.4K | 0.08% | 181 |
|
|
2023
Q3 | $233K | Buy |
12,516
+510
| +4% | +$9.48K | 0.06% | 278 |
|
|
2023
Q2 | $304K | Sell |
12,006
-240
| -2% | -$6.08K | 0.07% | 248 |
|
|
2023
Q1 | $317K | Sell |
12,246
-1,032
| -8% | -$26.7K | 0.08% | 246 |
|
|
2022
Q4 | $314K | Sell |
13,278
-3,193
| -19% | -$75.5K | 0.08% | 247 |
|
|
2022
Q3 | $418K | Buy |
16,471
+404
| +3% | +$10.3K | 0.11% | 183 |
|
|
2022
Q2 | $534K | Buy |
16,067
+4,087
| +34% | +$136K | 0.1% | 209 |
|
|
2022
Q1 | $864K | Buy |
+11,980
| New | +$864K | 0.15% | 170 |
|
|
2021
Q3 | $786K | Buy |
6,195
+1,365
| +28% | +$173K | 0.14% | 175 |
|
|
2021
Q2 | $803K | Buy |
4,830
+639
| +15% | +$106K | 0.15% | 167 |
|
|
2021
Q1 | $762K | Buy |
4,191
+77
| +2% | +$14K | 0.16% | 149 |
|
|
2020
Q4 | $823K | Buy |
4,114
+185
| +5% | +$37K | 0.18% | 129 |
|
|
2020
Q3 | $861K | Buy |
3,929
+2,785
| +243% | +$610K | 0.22% | 111 |
|
|
2020
Q2 | $218K | Buy |
1,144
+389
| +52% | +$74.1K | 0.08% | 224 |
|
|
2020
Q1 | $117K | Buy |
755
+255
| +51% | +$39.5K | 0.05% | 301 |
|
|
2019
Q4 | $42K | Buy |
+500
| New | +$42K | 0.02% | 528 |
|